Blog

Article

Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

Author(s):

Fact checked by:

Key Takeaways

  • An anaphylactic reaction to Paraplatin necessitated a switch to Cytoxan, requiring patient advocacy for insurance approval.
  • Pinch-off syndrome with the port-a-cath led to a replacement surgery, improving treatment comfort and productivity.
SHOW MORE

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.

Image of advocacy

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.

The first time I was treated for HER2-positive breast cancer, Paraplatin was administered without any negative reaction. Five years later, two small tumors returned in my right breast and a mastectomy was required. After healing from the surgery, chemotherapy was recommended a second time. During the second Paraplatin treatment, I experienced an anaphylactic reaction that restricted my breathing and caused me to turn purple. A “Code Blue” was called in the infusion room. There were so many white coats surrounding me I thought the angels had come for me. Two bags of Benadryl and a bag of Ativan later, I was able to breathe without trouble. I was told that I couldn’t drive myself home, so I called a friend to pick me up. The next day we drove back to get my car.

Two weeks later, while receiving my next chemotherapy treatment, I asked my nurse to check the pharmacy for the Cytoxan IV that I was supposed to receive. The look on her face when she returned told me there was a problem. She said the insurance company hadn’t approved it.

While I had three IV lines going into my port, I called my health insurance company. I was told by the customer service agent that the request for Cytoxan had been peer reviewed and denied. I advised the agent that I’d experienced an anaphylactic reaction the last time Paraplatin had been administered and that I did not receive a complete treatment because of it. In a calm voice, I emphasized that I wasn’t leaving the infusion room that day until I received a complete treatment. What could be done to expedite my request? After several minutes on hold, the agent returned with a fax number for my oncologist to send a clinical explanation for the change of chemotherapy drug. The information was then given to my infusion room nurse, who handed it to my oncologist’s nurse. It was Friday at 1:38 p.m. — what were the chances that I would receive a complete treatment before they closed at 5 p.m.? I know that I did all I could do to get the ball rolling.

Forty minutes later, my infusion room nurse returned with a big smile on her face and an IV bag of Cytoxan in her arms. She told me that she’d never seen anybody advocate for themselves like I had that day. I told her to “hang it high.” I did receive a complete treatment after all.

During my second series of chemotherapy treatments, the infusion pump alarm went off because the line was being pinched off inside the port-a-cath. Every time I moved or shifted position, the alarm went off. The infusion nurse, busy with several other patients, advised me that I would have to lie flat on the recliner for the rest of the day. I was unable to sit up to read or write. As I lay there for the entire day, tears poured down the sides of my face. I felt helpless and frustrated, unable to move for hours. I had three and a half more months of chemotherapy to complete. Lying flat on my back for the remainder of the treatments was not workable. I was using a laptop to keep up with emails from work while I was there.

I called my general surgeon who had inserted the port-a-cath. I explained that there was a problem with the port, that I had to lie still and flat for the entire day while receiving treatment. He spoke to my infusion room nurse who advised him that I was experiencing pinch-off syndrome. He agreed that I needed a new port-a-cath and quickly scheduled another surgery to replace it. There was no warranty with the port, so I had to pay twice for the facility fee, anesthesia, surgeon and 20% of the cost. The result was that I was able to sit up and be productive during the remaining treatments, plus my infusion room nurses’ job was made easier.

Advocating for oneself can be nerve-wracking but must be done calmly, respectfully and clearly for maximum results.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of Doctor.
Related Content